FNA of misclassified primary malignant neoplasms of the thyroid: Impact on clinical management

CytoJournal

Volumn 6, Issue , 2009, Pages

  Shah, Sejal ^a   Faquin, William ^b   Izquierdo, Roberto ^c   Khurana, Kamal ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Fine needle aspiration; management; misclassified neoplasms; thyroid

Indexed keywords

CALCITONIN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CLINICAL ARTICLE; CLINICAL STUDY; CONSULTATION; CYTODIAGNOSIS; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; MALE; SAMPLING; THYROID CANCER; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

EID: 77956585631     PISSN: 09745963     EISSN: 17426413     Source Type: Journal    
DOI: 10.4103/1742-6413.45191     Document Type: Article

References (26)

1. Piromalli D, Martelli G, Del Prato I, Collini P, Pilotti S. The role of fine needle aspiration in the diagnosis of thyroid nodules: Analysis of 795 consecutive cases. J Surg Oncol 1992;50:247-50.
2. Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: An appraisal. Ann Intern Med 1993;118:282-9.
3. Baloch ZW, Sack MJ, Yu GH, Livolsi VA, Gupta PK. Fine-needle aspiration of thyroid: An institutional experience. Thyroid 1998;8:565-9.
4. Ravetto C, Colombo L, Dottorini ME. Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: A retrospective study in 37,895 patients. Cancer 2000;90:357-63.
5. Zagorianakou P, Malamou-Mitsi V, Zagorianakou N, Stefanou D, Tsatsoulis A, Agnantis NJ. The role of fine-needle aspiration biopsy in the management of patients with thyroid nodules. In Vivo 2005;19:605-9.
6. Gharib H, Goellner JR. Evaluation of nodular thyroid disease. Endocrinol Metab Clin North Am 1988;17:511-26.
7. DeMay RM. Fine needle aspiration biopsy: The best test. In: Demay RM, editor. The Art and Science of Cytopathology. ASCP Press 1999. p. 709-12.
8. Yang YJ, LiVolsi VA, Khurana KK. Papillary thyroid carcinoma with nodular fasciitis-like stroma: Pitfalls in fine-needle aspiration cytology. Arch Pathol Lab Med 1999;123:838-41.
9. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-95.
10. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53.
11. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, et al. A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033-41.
12. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid carcinoma: American Association of Clinical Endocrinologists: American College of Endocrinology. Endocr Pract 2001;7:202-20.
13. Weber T, Schilling T, Buchler MW. Thyroid carcinoma. Curr Opin Oncol 2006;18:30-5.
14. Lal G, Clark OH. Thyroid, parathyroid and adrenal. In Schwartz′s Principles of Surgery, 8th ed New York, NY: McGraw-Hill Professional; 2005.
15. Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery; 1998:124, 958-64
16. Scopa CD, Melachrinou M, Saradopoulou C, Merino MJ. The significance of the grooved nucleus in thyroid lesions. Mod Pathol 1993;6:691-4.
17. Lew W, Orell S, Henderson DW. Intranuclear vacuoles in nonpapillary carcinoma of the thyroid: A report of three cases. Acta Cytol 1984;28:581-6.
18. Glant MD, Berger EK, Davey DD. Intranuclear cytoplasmic inclusions in aspirates of follicular neoplasms of the thyroid: A report of two cases. Acta Cytol 1984;28:576-80.
19. Thranov I, Francis D, Olsen J. Intranuclear cytoplasmic invaginations in a Hurthle-cell carcinoma of the thyroid. Acta Cytol 1983;27:341-4.
20. Guiter GE, Auger M, Ali SZ, Allen EA, Zakowski MF. Cytopathology of insular carcinoma of the thyroid. Cancer 1999;87:196-202.
21. Bergsagel DE. Rider: Plasma cell neoplasms. In: DeVita VT, Hellman S, Rosenberg S, editors. Cancer, principles and practice of oncology. Philadelphia: J.B. Lippincott 1988. p. 1753-95.
22. Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic thyroid cancer. Endocrinol Metab Clin North Am 2008;37:525-38.
23. Morrison C, Wakely P Jr. Aspiration cytopathology of metastatic mucinous papillary thyroid carcinoma. Mod Pathol 2001;14:361-5.
24. Chan JK, Tse CC. Mucin production in metastatic papillary carcinoma of the thyroid. Hum Pathol 1988;19:195-200.
25. Backdahl M, Wallin G, Lowhagen T, Auer G, Granberg PO. Fine-needle biopsy cytology and DNA analysis: Their place in the evaluation and treatment of patients with thyroid neoplasms. Surg Clin North Am 1987;67:197-211.
26. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, et al. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: Experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 2004;89:163-8.